{"url_path":"/sec/ehc/8-k/2026-05-15/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/785161/0000785161-26-000156-index.html","accession_number":"0000785161-26-000156","cik":"0000785161","ticker":"EHC","issuer_name":"Encompass Health Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/785161/0000785161-26-000156-index.html","primary_entity_key":"0000785161","primary_entity_name":"Encompass Health Corp"},"word_count":129,"has_tables":true,"body_markdown":"Item 8.01. Other Events.\n\nOn May 14, 2026, the Company issued a press release, made pursuant to Rule 135c promulgated under the Securities Act of 1933, as amended, announcing the pricing of the Notes Offering. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.\n\nThe forward-looking statements contained in this Form 8-K are qualified by the information contained under the heading “Forward-Looking Statements” in the press release attached as Exhibit 99.1 hereto. This Current Report on Form 8-K (and Exhibit 99.1 hereto) shall not constitute an offer to sell or the solicitation of an offer to buy the Notes and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful."}